Skip to main content
Toggle navigation
Login
Search
Home
Scientific Program
Poster Schedule
Home
Poster Schedule
All Days
Tue, Jun 20
Wed, Jun 21
Thu, Jun 22
Poster Schedule
Type here to filter the list
Tuesday, June 20, 2023
6:00 PM – 7:45 PM
Tu154 - Efficacy and Safety of Ebdarokimab, in Subjects with Moderate to Severe Ulcerative Colitis: Results from a Randomized, Double-blind, Placebo-controlled, Single-dose Escalation Phase Ib Clinical Study
Favorite
6:00 PM – 7:45 PM
Tu101 - 18F-FDG PET/CT Mapping of Functional Microbial Niches to Understand Host Glucose Regulation After BCG Vaccinations
Favorite
6:00 PM – 7:45 PM
Tu102 - A Bioluminescent Homogeneous Immunoassay to Detect Binding and Neutralising Anti-interferon Gamma antibodies Using Nanobit® Technology
Favorite
6:00 PM – 7:45 PM
Tu104 - Additive Efficacy of a Novel Bispecific anti-tnf/il-6 NANOBODY® Compound in Translational Models of Rheumatoid Arthritis
Favorite
6:00 PM – 7:45 PM
Tu105 - Adult-onset Still’s Disease in a Young Adult Patient Presenting as Fever of Unknown Origin Treated with Tocilizumab: A Case Report
Favorite
6:00 PM – 7:45 PM
Tu106 - An Efficient Functional Assay Platform of Autoimmunity Risk Alleles Using CRISPR Genome Editing
Favorite
6:00 PM – 7:45 PM
Tu107 - An Endogenous Metabolite, Itaconate Ameliorates Collagen-induced Arthritis by Inhibiting Fibroblast-like Synoviocytes Proliferation and Migration
Favorite
6:00 PM – 7:45 PM
Tu108 - An Inducible Mouse Model of Primary Cicatrcial Alopecia Exhibits Loss of CD200R
Favorite
6:00 PM – 7:45 PM
Tu109 - ANA+ igg Memory B Cells Are Hyperreactive in SLE
Favorite
6:00 PM – 7:45 PM
Tu110 - anti-cd45rc Mab Treatment Improves Experimental Inflammatory Bowel Disease (IBD)
Favorite
6:00 PM – 7:45 PM
Tu111 - Antigen-driven B Cell Expansion Differentiates Patients with Non-infectious Uveitis
Favorite
6:00 PM – 7:45 PM
Tu112 - CD47 Antibody Therapy Protects Circulating Cells from Immune Destruction
Favorite
6:00 PM – 7:45 PM
Tu113 - Characterizing Skin Resident and Recirculating Memory T-cells in Human and Murine Cutaneous Lupus Erythematosus
Favorite
6:00 PM – 7:45 PM
Tu114 - CUE-401: A Novel il-2/tgf-beta Fusion Protein for the Induction of CD4+ FOXP3+ Regulatory T Cells
Favorite
6:00 PM – 7:45 PM
Tu116 - Divergent Effects of JAK Inhibitors on B Cell Activation, Maturation and Function
Favorite
6:00 PM – 7:45 PM
Tu117 - Dynamic Regulatory Elements in Single-cell Multimodal Data Capture Autoimmune Disease Heritability and Implicate Key Immune Cell States
Favorite
6:00 PM – 7:45 PM
Tu118 - Early Immune Responses to sars-cov-2 Mrna Vaccination in the Skin of Patients on B-cell Depletion Therapy
Favorite
6:00 PM – 7:45 PM
Tu119 - Effect of AHSCT on Inflammatory Mediators in Serum and CSF of RRMS Patients in the HALT-MS Study
Favorite
6:00 PM – 7:45 PM
Tu120 - Efficient Control of Experimental Rheumatoid Arthritis (RA) by anti-cd45rc Mab Therapy
Favorite
6:00 PM – 7:45 PM
Tu121 - Emergence of HLA-DR+ CD15+ ‘hybrid’ Cells in Active Rheumatoid Arthritis (RA)
Favorite
6:00 PM – 7:45 PM
Tu122 - Enrichment of PD-1+TIGIT+ CD4 Effector Memory Cells After Alefacept Treatment in Type 1 Diabetes
Favorite
6:00 PM – 7:45 PM
Tu123 - Exacerbation of Sensorineural Hearing Loss (SNHL) After COVID -19 Infection and COVID-19 Vaccination in AIED Patients
Favorite
6:00 PM – 7:45 PM
Tu124 - Functionally Stable and Suppressive Regulatory T Cells Are Expanded with a Novel Engineered IL-2 Mutein
Favorite
6:00 PM – 7:45 PM
Tu125 - Granzyme K Activates a New Complement Pathway
Favorite
6:00 PM – 7:45 PM
Tu126 - High-throughput Western Blot for in Vitro and in Vivo Assessment of Human Ig Specific Cleaving Enzymes
Favorite
6:00 PM – 7:45 PM
Tu127 - HLA Class II Association of Autoantibodies Against GAD65 in North Indian Type 1 Diabetes Patients
Favorite
6:00 PM – 7:45 PM
Tu128 - HLA, KIR and Genetics of Anti-nmdar Encephalitis
Favorite
6:00 PM – 7:45 PM
Tu129 - Human T Cell Behavior in Lymphopenic Environments: Contribution of Lymphopenia-induced Proliferation to Autoimmunity
Favorite
6:00 PM – 7:45 PM
Tu130 - Humanized in Vivo Models Supporting the Identification of Novel Inhibitory Receptor Agonists for the Treatment of Immune-mediated Diseases
Favorite
6:00 PM – 7:45 PM
Tu131 - Hybrid Insulin Peptides Activate Autoreactive T Cells Restricted by a Non-risk HLA Haplotype
Favorite
6:00 PM – 7:45 PM
Tu132 - Identification and Characterization of Inhibitory Receptor Agonists for the Treatment of Autoimmune and Inflammatory Diseases
Favorite
6:00 PM – 7:45 PM
Tu133 - Identification and Characterization of Selective Fcγriib Binders and Their Potential Of impacting Immune-mediated Diseases
Favorite
6:00 PM – 7:45 PM
Tu134 - Identifying Next Generation Ig Selective Cleaving Enzymes for Treatment of Autoimmune Diseases Using IMPACT Platform
Favorite
6:00 PM – 7:45 PM
Tu135 - Immune Cell Heterogeneity in Lupus Nephritis Kidneys and Its Relation to Histopathological Features: Lessons from the Accelerating Medicines Partnership (AMP) in SLE Consortium
Favorite
6:00 PM – 7:45 PM
Tu136 - Immune Responses to Gut Bacteria Associated with Time to Diagnosis and Clinical Response to T-cell Directed Therapy for Type 1 Diabetes Prevention
Favorite
6:00 PM – 7:45 PM
Tu138 - Impact of Liraglutide Treatment on Gene Expression in Peripheral T-cell Populations from Adults with Recently Diagnosed Type 1 Diabetes
Favorite
6:00 PM – 7:45 PM
Tu139 - Impacting Autoimmunity Through Dual Targeting of Antigen Presenting Cells and T Cells via Inhibitory Receptor Agonism
Favorite
6:00 PM – 7:45 PM
Tu140 - Impaired Thymocyte Selection in Type 1 Diabetic Immune Systems
Favorite
6:00 PM – 7:45 PM
Tu141 - In Depth Transcriptomic Analysis of Myeloid Populations from Health to Disease in Rheumatoid Arthritis
Favorite
6:00 PM – 7:45 PM
Tu142 - In Vivo PK/PD Assessment of Invisibilized Igg Cleaving Protease for Chronic Treatment of Autoimmune Diseases
Favorite
6:00 PM – 7:45 PM
Tu143 - In vivo Reprograming of Stromal Cells for Tolerogenic Immunotherapy Using Mrnas with Restricted Expression
Favorite
6:00 PM – 7:45 PM
Tu144 - Mechanisms of Type I Interferon-mediated UVB Sensitivity in Human Keratinocytes
Favorite
6:00 PM – 7:45 PM
Tu145 - Metabolic Regulation of Human B-cell Effector Cytokines in Health and Disease
Favorite
6:00 PM – 7:45 PM
Tu146 - Metabolomics Analysis Reveals Common and Differentiating Metabolic Phenotypes in Peripheral Blood Mononuclear Cells from Type 1 Diabetes, Systemic Lupus Erythematosus and Healthy Participants
Favorite
6:00 PM – 7:45 PM
Tu147 - Mitochondrial Defects Caused by Tissue Inflammation: New Hints from Spatial Transcriptomics in a Model of Myositis
Favorite
6:00 PM – 7:45 PM
Tu148 - Modulation of the T Cell Phenotype by Vitamin D Supplementation in MS
Favorite
6:00 PM – 7:45 PM
Tu149 - Multiparametric Comparison of the Adult-onset and Childhood-onset Systemic Lupus Erythematosus (SLE) Immunomes Reveals Multiple Derangements
Favorite
6:00 PM – 7:45 PM
Tu150 - Multiple Sclerosis Patients Under Long-term Fingolimod Treatment Fail to Elicit Humoral and Cellular Immune Responses upon Repeated sars-cov-2 Mrna Vaccinations
Favorite
6:00 PM – 7:45 PM
Tu151 - Myeloid-derived Suppressor Cells Showed Differential Recruitment in SLE Animals Contributing to the Pathology
Favorite
6:00 PM – 7:45 PM
Tu152 - rab4a Controls the Depletion of IL-2 in CD4+ T Cells via Enhanced CD38 Expression: Potential Involvement in Proinflammatory Lineage Development in Systemic Lupus Erythematosus
Favorite
6:00 PM – 7:45 PM
Tu153 - Therapy of Atypical Hemolytic Uremia Syndrome(ahus)
Favorite
6:00 PM – 7:45 PM
Tu155 - A 47-marker Immune Profiling Flow Cytometry Assay to Enable Comprehensive Antigen-specific Immune Analysis
Favorite
6:00 PM – 7:45 PM
Tu156 - A High-throughput Solution for Building Tcr-antigen Maps at Single Cell Resolution
Favorite
6:00 PM – 7:45 PM
Tu157 - Age Influences Immunotype Diversity in Healthy Adults
Favorite
6:00 PM – 7:45 PM
Tu158 - Antigen-driven Epigenetic Rewiring Drives Rapid Exhaustion of Memory T Cells in Progressing Tumors
Favorite
6:00 PM – 7:45 PM
Tu159 - Characterizing Quantitative Properties of T-cell Repertoires Across Disease Categories
Favorite
6:00 PM – 7:45 PM
Tu160 - Clinical Outcome of Dominant Negative Mutation in Caspase Activation and Recruitment Domain Family Member 11 (CARD11)
Favorite
6:00 PM – 7:45 PM
Tu161 - Delay in Peripheral Blood Processing Depletes Monocytes While B and T Cell Populations Are Maintained
Favorite
6:00 PM – 7:45 PM
Tu162 - Functional Overlap of Inborn Errors of Immunity and Metabolism Genes Define T Cell Immunometabolic Vulnerabilities
Favorite
6:00 PM – 7:45 PM
Tu163 - Germline-encoded Amino Acid-binding Motifs Drive Immunodominant Public Antibody Responses
Favorite
6:00 PM – 7:45 PM
Tu164 - Group Similarity Analysis (GSA) Is a Visualization Method to Evaluate Batch Effects and Sample Stratification in High-dimensional Mass Cytometry Data
Favorite
6:00 PM – 7:45 PM
Tu165 - Heterogeneous Regulation of IL-10 Expression in B-cell Subsets
Favorite
6:00 PM – 7:45 PM
Tu166 - Human Femoral Atheroma Exhibit Enhanced Myeloid Inflammation-resolving Potential and Reduced Inflammatory Monocyte Mobilization Compared with Human Carotid Atheroma
Favorite
6:00 PM – 7:45 PM
Tu167 - Hypoxia Stimulates Neonatal hif-1a Dependent Macrophage Secretion of Cardiomyocyte Mitogens
Favorite
6:00 PM – 7:45 PM
Tu168 - Impact of slc11a1 Gene Variants on Host Response and Tissue Repair After Ti Implantation
Favorite
6:00 PM – 7:45 PM
Tu169 - Retinoic Acid-related Orphan Receptor Alpha Expression Differentiates Distinct Populations of Human Group 2 Innate Lymphoid Cells
Favorite
6:00 PM – 7:45 PM
Tu170 - TRPV2 Plays a Critical Role in Hepoxilin a3-medited Neutrophil Transepithelial Chemotaxis
Favorite
6:00 PM – 7:45 PM
Tu171 - A Novel Human Immune System Mouse Model for COVID-19
Favorite
6:00 PM – 7:45 PM
Tu172 - Association of COVID-19 and Development of Type 1 Diabetes - A Danish Nationwide Register Study
Favorite
6:00 PM – 7:45 PM
Tu173 - Behavioral Change in Response to COVID-19 Restrictions Among People with and Without Diabetes: A Retrospective Case-control Study in Denmark
Favorite
6:00 PM – 7:45 PM
Tu174 - Characterization of a Poly (allylamine Hydrochloride) Nanoparticle-based Adjuvant That Provides a Rapid and Broad Mucosal Immune Activation
Favorite
6:00 PM – 7:45 PM
Tu175 - Characterization of the T Cell Responses Elicited by Four Doses of an Inactivated sars-cov-2 Vaccine in Adults
Favorite
6:00 PM – 7:45 PM
Tu176 - COVID-19 Vaccines as a Testing Agent for Allergy Diagnosis
Favorite
6:00 PM – 7:45 PM
Tu177 - Features of Humoral Immunity to sars-cov-2 in Kidney Transplant Recipients
Favorite
6:00 PM – 7:45 PM
Tu178 - Investigating Links Between Persistent Symptoms After COVID-19 and Longitudinal Changes in Memory T Cell Responses to EBV, CMV, HSV-1, and sars-cov-2
Favorite
6:00 PM – 7:45 PM
Tu179 - Longitudinal Analysis After sars-cov-2 Infection and Vaccination in LA-SPARTA: A Cohort of High-risk Individuals
Favorite
6:00 PM – 7:45 PM
Tu180 - Characterization of CD19 CAR T Cells Produced in Hypoxia
Favorite
6:00 PM – 7:45 PM
Tu181 - Chimeric Autoantigen-t Cell Receptor (CATCR)-T Cell Therapies to Selectively Target Autoreactive B Cells
Favorite
6:00 PM – 7:45 PM
Tu183 - Clinical Characteristics Associated with Early Immune Reconstitution in Patients with Congenital Athymia After Treatment with Allogeneic Processed Thymus Tissue-agdc
Favorite
6:00 PM – 7:45 PM
Tu184 - Colon Cancer Immune Therapy and Prophylaxis
Favorite
6:00 PM – 7:45 PM
Tu185 - Combining Human CD4+ and CD8+ Treg to Inhibit Experimental Acute GVHD
Favorite
6:00 PM – 7:45 PM
Tu186 - Engineering Genetic Circuits to Promote Tumor Allorejection for Immunotherapy of Solid Cancers
Favorite
6:00 PM – 7:45 PM
Tu187 - Enhancing TCR Efficacy Through CD3ζ Modifications
Favorite
6:00 PM – 7:45 PM
Tu189 - Expansion of EBV Peptide-specific CD8 T Cells from Multiple Sclerosis Patients and Healthy Donors Reveals Dysregulation of Effector Responses That May Be Associated with Disease Pathogenesis
Favorite
6:00 PM – 7:45 PM
Tu190 - T-cell Mediated Immune Responses Induced by anti-cd19 Chimeric Antigen Receptor (ARI-0001) in Patients with CD19 Positive B-cell Malignancies
Favorite
6:00 PM – 7:45 PM
Tu191 - A Human ITPR3 Variant Causes Immunodeficiency and Growth Delay by Negatively Impacting Calcium Responses
Favorite
6:00 PM – 7:45 PM
Tu192 - Alterations in Circular RNA Landscape in Septic Peripheral Blood Mononuclear Cells Before and After Intensive Care
Favorite
6:00 PM – 7:45 PM
Tu193 - Decoding Regulatory T Cell Identity and Stability to Inform Better Regulatory T Cell Therapies
Favorite
6:00 PM – 7:45 PM
Tu194 - Delineating Target Genes for Autoimmune Disease-associated Enhancer Variants Using 3D Genomics
Favorite
6:00 PM – 7:45 PM
Tu195 - Long-term Evaluation of Good’s Syndrome Reveals a Unique Adult-onset Progressive Immune Deficiency
Favorite
6:00 PM – 7:45 PM
Tu197 - ADIPOSE-DERIVED, her2/neu TUMOR-TARGETED, HUMAN MAST CELLS HAVE ANTITUMOR EFFECTS IN VIVO AFTER I.V. INJECTION
Favorite
6:00 PM – 7:45 PM
Tu198 - Association of Treatment Outcomes with Fc-dependent Antibody Effector Functions Using Systems Serology
Favorite
6:00 PM – 7:45 PM
Tu199 - Automated Gating of Pharmacodynamic Biomarker Expedites Data Analysis and Enables Novel Biomarker Exploration in Preclinical Studies
Favorite
6:00 PM – 7:45 PM
Tu200 - Characterising the Tumour-associated Regulatory T Cell (Treg) Niche
Favorite
6:00 PM – 7:45 PM
Tu201 - Characterization of Myeloid-derived Suppressor Cells in Response to Restraint Stress in Preclinical Models of Ovarian Cancer
Favorite
6:00 PM – 7:45 PM
Tu202 - CHRM4 Promotes Immunosuppressive Response in the Tumor Microenvironment to Promote Neuroendocrine Differentiation of Prostate Cancer
Favorite
6:00 PM – 7:45 PM
Tu203 - Circulating Tumor DNA and T Cells Expressing PD-1 and CD39 Enable Neoantigen-targeted T-cell Therapies from Liquid Biopsies
Favorite
6:00 PM – 7:45 PM
Tu204 - Clonally Expanded cd38hi Cytotoxic CD8 T Cells Define the T Cell Infiltrate in Checkpoint Inhibitor-associated Arthritis
Favorite
6:00 PM – 7:45 PM
Tu205 - Cytokines Surge in the Blood Years Before a Cancer Diagnosis in Elderly Individuals
Favorite
6:00 PM – 7:45 PM
Tu206 - Development of a Macrophage-based Prognostic Scoring System and Evaluation of Bufalin as a Macrophage Phenotype Modulator in Head and Neck Cancer Using 2D and 3D Models
Favorite
6:00 PM – 7:45 PM
Tu207 - Differential Benefit and Safety of Neoadjuvant Chemotherapy in Patients with Breast Cancer According to Pretreatment Serum Prealbumin Levels
Favorite
6:00 PM – 7:45 PM
Tu208 - Vitamin B5 Enhances the Antitumor Activity of Human Vγ9Vδ2-T Cells
Favorite
6:00 PM – 7:45 PM
Tu209 - Characterization of Neuroimmunological Alterations Induced by Infection with the Human Respiratory Syncytial Virus
Favorite
6:00 PM – 7:45 PM
Tu210 - Characterization of T Cell-mediated Immunity Against Oral Keratinocytes Infected with Intracellular Bacteria
Favorite
6:00 PM – 7:45 PM
Tu211 - Comparative Single Cell Analysis Reveals Distinct Transcriptional and Epigenetic Immune Signatures of sars-cov-2 and Respiratory Syncytial Virus Infections in Infants
Favorite
6:00 PM – 7:45 PM
Tu212 - Deciphering Human Immune Responses in Infection Diseases Using Machine Learning
Favorite
6:00 PM – 7:45 PM
Tu213 - Developing a Vaccine for Dracunculus Medinensis (Guinea Worm)
Favorite
6:00 PM – 7:45 PM
Tu214 - Therapy of Multi Drug Resistant Neisseria Gonorrhoeae
Favorite
6:00 PM – 7:45 PM
Tu215 - A Deep Dive into a Wide Spectrum: Redefining Blood Cell States in Health and Disease
Favorite
6:00 PM – 7:45 PM
Tu217 - A Humanized Mouse Model of VEO-IBD by crispr/cas9 Editing of the IL10 Gene in Human Hspcs
Favorite
6:00 PM – 7:45 PM
Tu219 - ACE2 Expression in the Liver of Obese People Is Associated with Anthropometric, Biochemical, and Proinflammatory Cytokine Variables
Favorite
6:00 PM – 7:45 PM
Tu220 - Agonist anti-chemr23 Mab Inhibits Netosis and Neutrophil-mediated Inflammation
Favorite
6:00 PM – 7:45 PM
Tu221 - ALTB-168, an Immune Checkpoint Enhancer (ICE) Targeting P-selectin glycoprotein-1 (PSGL-1), Is Effective in Treating T-cell Mediated Inflammatory Diseases
Favorite
6:00 PM – 7:45 PM
Tu222 - Alterations in the Gut Microbiota in Advanced Age-related Macular Degeneration May Be Involved in Its Pathogenesis
Favorite
6:00 PM – 7:45 PM
Tu223 - Anti-tnf Treatment Response Classifier for Inflammatory Bowel Disease Patients
Favorite
6:00 PM – 7:45 PM
Tu224 - Asthmagraph – Knowledge Graph Framework for Drug Target Prioritization in Asthma
Favorite
6:00 PM – 7:45 PM
Tu225 - Clinical Outcomes of Adalimumab in Real-world Treatment of Non-infectious Uveitis from a Single Tertiary Center in Tokyo
Favorite
6:00 PM – 7:45 PM
Tu226 - Constitutive IL-1RA Production by Modified Immune Cells Protects Against Tissue and Systemic il-1-mediated Inflammatory Disorders
Favorite
6:00 PM – 7:45 PM
Tu227 - Drug Induced Interstitial Lung Disease and Inhibitors of Interleukin 1 and Interleukin 6
Favorite
6:00 PM – 7:45 PM
Tu228 - Therapy of C3 Glomerulopathy
Favorite
6:00 PM – 7:45 PM
Tu229 - A Role for Iga in GZMB+ Regulatory B Cells in Tolerance
Favorite
6:00 PM – 7:45 PM
Tu230 - Adoptive Transfer of Group 2 and Group 3 Innate Lymphoid Cells Prevents Rejection in Humanized Models of Islet Transplant
Favorite
6:00 PM – 7:45 PM
Tu231 - Assessment of Hematological Parameters of Petrol Filling Workers at Petrol Stations in Gondar Town, Northwest Ethiopia: A Comparative Cross-sectional Study
Favorite
6:00 PM – 7:45 PM
Tu233 - Comparison of the Occurrences of Long-term Toxicities in Patients Who Received Allogeneic Hematopoietic Stem-cell Transplantation with or Without Total Body Irradiation
Favorite
